In this piece for TIME, Mandy Oaklander provides a comprehensive review of the current status of and potential future directions for the depression treatment industry. The article explores the pluses and minuses of various new treatments for depression, including the use of ketamine, and also describes non-drug approaches including exercise, CBT, and behavioral-activation therapy.
Enjoyed what you just read? Consider a donation to help us continue to produce content, provide up-to-date research news, offer continuing education courses, and continue building a community for exploring alternatives to the current paradigm of mental health. All donations are tax deductible.